PARP inhibition in prostate cancer
Defects in DNA damage repair genes are more common in prostate cancer than previously thought. These alterations provide an opportunity for precision oncology approaches and a number of studies have now shown that PARP inhibitors can have significant antitumor activity in men with DNA damage repair-...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2021
|
| In: |
Genes, chromosomes & cancer
Year: 2021, Jahrgang: 60, Heft: 5, Pages: 344-351 |
| ISSN: | 1098-2264 |
| DOI: | 10.1002/gcc.22903 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1002/gcc.22903 Verlag, kostenfrei, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/gcc.22903 
|
| Verfasserangaben: | Cathleen Nientiedt, Anette Duensing, Stefanie Zschäbitz, Dirk Jäger, Markus Hohenfellner, Albrecht Stenzinger, Stefan Duensing |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 178039019X | ||
| 003 | DE-627 | ||
| 005 | 20220208210158.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 211206s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/gcc.22903 |2 doi | |
| 035 | |a (DE-627)178039019X | ||
| 035 | |a (DE-599)KXP178039019X | ||
| 035 | |a (OCoLC)1295644513 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Nientiedt, Cathleen |e VerfasserIn |0 (DE-588)1162095288 |0 (DE-627)1025532813 |0 (DE-576)507145070 |4 aut | |
| 245 | 1 | 0 | |a PARP inhibition in prostate cancer |c Cathleen Nientiedt, Anette Duensing, Stefanie Zschäbitz, Dirk Jäger, Markus Hohenfellner, Albrecht Stenzinger, Stefan Duensing |
| 264 | 1 | |c 2021 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a First published: 21 October 2020 | ||
| 500 | |a Gesehen am 06.12.2021 | ||
| 520 | |a Defects in DNA damage repair genes are more common in prostate cancer than previously thought. These alterations provide an opportunity for precision oncology approaches and a number of studies have now shown that PARP inhibitors can have significant antitumor activity in men with DNA damage repair-deficient metastatic castration-resistant prostate cancer. This review summarizes the key clinical trials related to the use of PARP inhibitors in prostate cancer. Besides clinical outcomes, toxicity, and PARP inhibitor resistance, the role of different DNA repair genes in the response to PARP inhibition will be discussed. | ||
| 650 | 4 | |a DNA damage repair genes | |
| 650 | 4 | |a PARP inhibition | |
| 650 | 4 | |a prostate cancer | |
| 700 | 1 | |a Duensing, Anette |e VerfasserIn |0 (DE-588)1186091703 |0 (DE-627)1665366486 |4 aut | |
| 700 | 1 | |a Zschäbitz, Stefanie |d 1983- |e VerfasserIn |0 (DE-588)1037698827 |0 (DE-627)75589894X |0 (DE-576)391727206 |4 aut | |
| 700 | 1 | |a Jäger, Dirk |d 1964- |e VerfasserIn |0 (DE-588)1032507535 |0 (DE-627)738505323 |0 (DE-576)380074125 |4 aut | |
| 700 | 1 | |a Hohenfellner, Markus |d 1958- |e VerfasserIn |0 (DE-588)133862518 |0 (DE-627)557857988 |0 (DE-576)300155263 |4 aut | |
| 700 | 1 | |a Stenzinger, Albrecht |e VerfasserIn |0 (DE-588)139606106 |0 (DE-627)703395238 |0 (DE-576)312432755 |4 aut | |
| 700 | 1 | |a Duensing, Stefan |d 1967- |e VerfasserIn |0 (DE-588)1074044487 |0 (DE-627)830213007 |0 (DE-576)435550098 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Genes, chromosomes & cancer |d New York, NY : Wiley-Liss, 1989 |g 60(2021), 5, Seite 344-351 |h Online-Ressource |w (DE-627)302922369 |w (DE-600)1492641-6 |w (DE-576)094400474 |x 1098-2264 |7 nnas |a PARP inhibition in prostate cancer |
| 773 | 1 | 8 | |g volume:60 |g year:2021 |g number:5 |g pages:344-351 |g extent:8 |a PARP inhibition in prostate cancer |
| 856 | 4 | 0 | |u https://doi.org/10.1002/gcc.22903 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1002/gcc.22903 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20211206 | ||
| 993 | |a Article | ||
| 994 | |a 2021 | ||
| 998 | |g 1074044487 |a Duensing, Stefan |m 1074044487:Duensing, Stefan |d 910000 |d 910200 |e 910000PD1074044487 |e 910200PD1074044487 |k 0/910000/ |k 1/910000/910200/ |p 7 |y j | ||
| 998 | |g 139606106 |a Stenzinger, Albrecht |m 139606106:Stenzinger, Albrecht |d 910000 |d 912000 |e 910000PS139606106 |e 912000PS139606106 |k 0/910000/ |k 1/910000/912000/ |p 6 | ||
| 998 | |g 133862518 |a Hohenfellner, Markus |m 133862518:Hohenfellner, Markus |d 910000 |d 910200 |e 910000PH133862518 |e 910200PH133862518 |k 0/910000/ |k 1/910000/910200/ |p 5 | ||
| 998 | |g 1032507535 |a Jäger, Dirk |m 1032507535:Jäger, Dirk |d 910000 |e 910000PJ1032507535 |k 0/910000/ |p 4 | ||
| 998 | |g 1037698827 |a Zschäbitz, Stefanie |m 1037698827:Zschäbitz, Stefanie |d 910000 |d 910100 |e 910000PZ1037698827 |e 910100PZ1037698827 |k 0/910000/ |k 1/910000/910100/ |p 3 | ||
| 998 | |g 1186091703 |a Duensing, Anette |m 1186091703:Duensing, Anette |d 910000 |d 910200 |e 910000PD1186091703 |e 910200PD1186091703 |k 0/910000/ |k 1/910000/910200/ |p 2 | ||
| 998 | |g 1162095288 |a Nientiedt, Cathleen |m 1162095288:Nientiedt, Cathleen |d 910000 |d 910100 |e 910000PN1162095288 |e 910100PN1162095288 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN178039019X |e 4014564991 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["First published: 21 October 2020","Gesehen am 06.12.2021"],"origin":[{"dateIssuedDisp":"2021","dateIssuedKey":"2021"}],"recId":"178039019X","relHost":[{"origin":[{"dateIssuedKey":"1989","dateIssuedDisp":"1989-","publisher":"Wiley-Liss","publisherPlace":"New York, NY"}],"note":["Gesehen am 14.12.07"],"pubHistory":["1.1989/90 -"],"recId":"302922369","language":["eng"],"id":{"issn":["1098-2264"],"doi":["10.1002/(ISSN)1098-2264"],"zdb":["1492641-6"],"eki":["302922369"]},"type":{"media":"Online-Ressource","bibl":"periodical"},"title":[{"title_sort":"Genes, chromosomes & cancer","title":"Genes, chromosomes & cancer"}],"part":{"issue":"5","volume":"60","extent":"8","text":"60(2021), 5, Seite 344-351","year":"2021","pages":"344-351"},"disp":"PARP inhibition in prostate cancerGenes, chromosomes & cancer","physDesc":[{"extent":"Online-Ressource"}]}],"language":["eng"],"name":{"displayForm":["Cathleen Nientiedt, Anette Duensing, Stefanie Zschäbitz, Dirk Jäger, Markus Hohenfellner, Albrecht Stenzinger, Stefan Duensing"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"family":"Nientiedt","given":"Cathleen","display":"Nientiedt, Cathleen","role":"aut"},{"role":"aut","display":"Duensing, Anette","given":"Anette","family":"Duensing"},{"family":"Zschäbitz","given":"Stefanie","display":"Zschäbitz, Stefanie","role":"aut"},{"family":"Jäger","given":"Dirk","display":"Jäger, Dirk","role":"aut"},{"given":"Markus","display":"Hohenfellner, Markus","role":"aut","family":"Hohenfellner"},{"family":"Stenzinger","given":"Albrecht","display":"Stenzinger, Albrecht","role":"aut"},{"role":"aut","given":"Stefan","display":"Duensing, Stefan","family":"Duensing"}],"title":[{"title":"PARP inhibition in prostate cancer","title_sort":"PARP inhibition in prostate cancer"}],"physDesc":[{"extent":"8 S."}],"id":{"eki":["178039019X"],"doi":["10.1002/gcc.22903"]}} | ||
| SRT | |a NIENTIEDTCPARPINHIBI2021 | ||